ENLIGHTED phase 3 study: Interim results of efficacy and safety of padeliporfin vascular targeted photodynamic therapy (VTP) in the treatment of low-grade upper tract urothelial cancer (LG UTUC) Meeting Abstract


Authors: Margulis, V.; Kaufman, R. P. Jr; Marcq, G.; Shvero, A.; Shore, N. D.; Psutka, S. P.; Uchio, E. M.; Djaladat, H.; Raman, J. D.; Shabsigh, A.; Colombel, M.; Aller, M.; Rausch, S.; Grubb, R.; Mroz, A.; Kudinova, N.; Cohen, Y.; Alpert, G.; Scherz, A. J.; Coleman, J.
Abstract Title: ENLIGHTED phase 3 study: Interim results of efficacy and safety of padeliporfin vascular targeted photodynamic therapy (VTP) in the treatment of low-grade upper tract urothelial cancer (LG UTUC)
Meeting Title: 2025 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 43
Issue: 17 Suppl.
Meeting Dates: 2025 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2025-06-10
Start Page: LBA4513
Language: English
ACCESSION: WOS:001511753400001
DOI: 10.1200/JCO.2025.43.17_suppl.LBA4513
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Coleman
    349 Coleman